
5 Prime Sciences helps biotech and pharma companies speed up the discovery and development of therapies using human genetics. It does this with an AI-driven analytics platform that analyzes genomics, proteomics, and metabolomics to identify and validate drug targets. The company concentrates on cardio-metabolic diseases and serves venture capital firms seeking biotech investments. Its technology stack and workflows are designed for business customers in biotech and pharma, enabling target prioritization and evidence generation. The market-scale comes from large pharma pipelines and biotech R&D needs.

5 Prime Sciences helps biotech and pharma companies speed up the discovery and development of therapies using human genetics. It does this with an AI-driven analytics platform that analyzes genomics, proteomics, and metabolomics to identify and validate drug targets. The company concentrates on cardio-metabolic diseases and serves venture capital firms seeking biotech investments. Its technology stack and workflows are designed for business customers in biotech and pharma, enabling target prioritization and evidence generation. The market-scale comes from large pharma pipelines and biotech R&D needs.